Drug target · TAAR1
TAAR1
Trace amine-associated receptor 1
3 compounds in the CNS pipeline act on TAAR1.
Compounds targeting TAAR1
| Compound | Action | Affinity | Lead program | Developer |
|---|---|---|---|---|
| Ulotaront (SEP-363856)primarySmall molecule | Agonist | EC50 38 nM | Phase 2/3Generalized anxiety disorder | Otsuka Pharmaceutical Co., Ltd. |
| Psilocybin (COMP360)Psychedelic | Agonist | Ki 1.4 nM | Phase 3Treatment-resistant depression | COMPASS Pathways plc |
| Solriamfetol (Sunosi)Small molecule | Agonist | — | Phase 3Major depressive disorder | Axsome Therapeutics, Inc. |